$2.84 Billion is the total value of Nantahala Capital Management's 136 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 36.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IWM | Sell | ISHARES TRput | $478,268,000 | -0.6% | 2,150,000 | -2.3% | 16.83% | +11.0% |
| W | WAYFAIR INCcall | $153,439,000 | -25.7% | 807,700 | 0.0% | 5.40% | -17.0% | |
| ESTA | Buy | ESTABLISHMENT LABS HLDGS INC | $143,510,000 | -2.5% | 2,123,236 | +3.2% | 5.05% | +8.8% |
| SGMS | SCIENTIFIC GAMES CORPcall | $104,208,000 | -19.5% | 1,559,300 | 0.0% | 3.67% | -10.2% | |
| CDXS | Sell | CODEXIS INC | $100,505,000 | +15.2% | 3,214,097 | -14.3% | 3.54% | +28.7% |
| XBI | Buy | SPDR SER TRput | $72,774,000 | +15.8% | 650,000 | +30.0% | 2.56% | +29.2% |
| THC | TENET HEALTHCARE CORPcall | $71,552,000 | +23.0% | 875,900 | 0.0% | 2.52% | +37.2% | |
| TA | TRAVELCENTERS OF AMERICA INC | $65,690,000 | +3.7% | 1,272,570 | 0.0% | 2.31% | +15.7% | |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $62,399,000 | +22.9% | 2,850,559 | +7.3% | 2.20% | +37.2% |
| MLHR | Sell | MILLERKNOLL INC | $57,394,000 | +3.8% | 1,464,507 | -0.3% | 2.02% | +15.8% |
| TNL | TRAVEL PLUS LEISURE COcall | $55,270,000 | +1.4% | 1,000,000 | 0.0% | 1.94% | +13.2% | |
| GDEN | Buy | GOLDEN ENTMT INC | $54,134,000 | +22.4% | 1,071,315 | +18.9% | 1.90% | +36.7% |
| CASH | Sell | META FINL GROUP INC | $53,443,000 | -11.5% | 895,792 | -22.2% | 1.88% | -1.3% |
| TNL | Buy | TRAVEL PLUS LEISURE CO | $52,023,000 | +2.3% | 941,252 | +1.0% | 1.83% | +14.2% |
| IMAX | Sell | IMAX CORP | $49,907,000 | -6.6% | 2,797,490 | -0.7% | 1.76% | +4.2% |
| QURE | Buy | UNIQURE NV | $49,015,000 | -13.0% | 2,363,313 | +34.3% | 1.72% | -2.9% |
| CVNA | CARVANA COcall | $47,216,000 | -23.1% | 203,700 | 0.0% | 1.66% | -14.2% | |
| KROS | Buy | KEROS THERAPEUTICS INC | $46,615,000 | +55.0% | 796,698 | +4.8% | 1.64% | +73.0% |
| XBI | New | SPDR SER TRcall | $44,784,000 | – | 400,000 | +100.0% | 1.58% | – |
| QURE | UNIQURE NVcall | $43,676,000 | -35.2% | 2,105,900 | 0.0% | 1.54% | -27.6% | |
| IMAX | Buy | IMAX CORPcall | $42,816,000 | +25.3% | 2,400,000 | +33.3% | 1.51% | +39.8% |
| LXFR | Buy | LUXFER HOLDINGS PLC | $40,903,000 | -1.4% | 2,118,233 | +0.3% | 1.44% | +10.1% |
| RDVT | Buy | RED VIOLET INC | $40,621,000 | +57.4% | 1,023,459 | +2.3% | 1.43% | +75.8% |
| IMTX | Buy | IMMATICS N.V | $39,227,000 | +14.0% | 2,918,662 | +10.2% | 1.38% | +27.2% |
| RMR | Buy | RMR GROUP INCcl a | $33,422,000 | +59.4% | 963,726 | +53.8% | 1.18% | +77.9% |
| PTON | Buy | PELOTON INTERACTIVE INCcall | $32,184,000 | +84.9% | 900,000 | +350.0% | 1.13% | +106.2% |
| APEN | Buy | APOLLO ENDOSURGERY INC | $31,712,000 | +39.2% | 3,761,783 | +49.6% | 1.12% | +55.4% |
| DXPE | Buy | DXP ENTERPRISES INC | $31,401,000 | -9.7% | 1,223,258 | +4.0% | 1.10% | +0.8% |
| CUE | Sell | CUE BIOPHARMA INC | $28,724,000 | -23.3% | 2,539,700 | -1.2% | 1.01% | -14.4% |
| ALTG | Buy | ALTA EQUIPMENT GROUP INC | $28,497,000 | +7.0% | 1,946,541 | +0.3% | 1.00% | +19.5% |
| IMXI | Buy | INTERNATIONAL MNY EXPRESS IN | $25,719,000 | +0.4% | 1,611,488 | +5.1% | 0.90% | +12.1% |
| SMLR | Buy | SEMLER SCIENTIFIC INC | $25,578,000 | +40.7% | 279,085 | +91.9% | 0.90% | +57.1% |
| PAYA | Buy | PAYA HOLDINGS INC | $24,092,000 | +49.6% | 3,799,961 | +156.6% | 0.85% | +67.3% |
| DHX | Buy | DHI GROUP INC | $23,251,000 | +44.7% | 3,726,184 | +10.4% | 0.82% | +61.7% |
| FBIO | Buy | FORTRESS BIOTECH INC | $22,715,000 | -13.3% | 9,086,005 | +11.6% | 0.80% | -3.3% |
| AUTL | Buy | AUTOLUS THERAPEUTICS PLCspon ads | $21,162,000 | +10.0% | 4,077,509 | +38.8% | 0.74% | +22.9% |
| Buy | DARIOHEALTH CORP | $18,310,000 | +26.1% | 1,411,681 | +32.7% | 0.64% | +40.6% | |
| TSHA | Buy | TAYSHA GENE THERAPIES INC | $16,964,000 | -27.1% | 1,456,147 | +16.6% | 0.60% | -18.6% |
| SC | New | SANTANDER CONSUMER USA HLDGS | $16,605,000 | – | 395,176 | +100.0% | 0.58% | – |
| VRM | New | VROOM INCcall | $16,185,000 | – | 1,500,000 | +100.0% | 0.57% | – |
| BBQ | BBQ HLDGS INC | $15,840,000 | +5.0% | 1,000,000 | 0.0% | 0.56% | +17.0% | |
| SWAV | New | SHOCKWAVE MED INCput | $14,266,000 | – | 80,000 | +100.0% | 0.50% | – |
| RDI | Buy | READING INTL INCcl a | $14,042,000 | -20.0% | 3,475,832 | +0.2% | 0.49% | -10.7% |
| SFT | Sell | SHIFT TECHNOLOGIES INCcl a | $14,039,000 | -54.8% | 4,116,943 | -8.0% | 0.49% | -49.5% |
| New | ZOGENIX INCnote 2.750%10/0 | $13,864,000 | – | 14,000,000 | +100.0% | 0.49% | – | |
| AGLE | Buy | AEGLEA BIOTHERAPEUTICS INC | $13,364,000 | +10.8% | 2,813,560 | +85.5% | 0.47% | +23.7% |
| Buy | AVALO THERAPEUTICS INC | $12,148,000 | -19.8% | 7,145,874 | +2.8% | 0.43% | -10.7% | |
| New | HELIOGEN INC | $12,021,000 | – | 775,001 | +100.0% | 0.42% | – | |
| Sell | FALCON MINERALS CORP | $11,565,000 | -1.4% | 2,374,707 | -4.8% | 0.41% | +10.0% | |
| CRIS | Sell | CURIS INC | $11,384,000 | -41.0% | 2,391,691 | -2.9% | 0.40% | -34.0% |
| HLF | HERBALIFE NUTRITION LTDcall | $11,379,000 | -3.4% | 278,000 | 0.0% | 0.40% | +7.8% | |
| AKBA | Sell | AKEBIA THERAPEUTICS INC | $11,116,000 | -22.5% | 4,918,565 | -1.2% | 0.39% | -13.5% |
| AKUMIN INC | $11,061,000 | -29.4% | 6,320,740 | 0.0% | 0.39% | -21.3% | ||
| Buy | APTOSE BIOSCIENCES INC | $10,266,000 | -36.0% | 7,604,693 | +3.4% | 0.36% | -28.5% | |
| FTVIU | FINTECH ACQUISITION CORP VIunit 06/24/2026 | $10,005,000 | +0.1% | 1,000,000 | 0.0% | 0.35% | +11.7% | |
| FTCV | FINTECH ACQUISITION CORP V | $9,835,000 | -2.1% | 991,432 | 0.0% | 0.35% | +9.5% | |
| IIII | INSU ACQUISITION CORP III | $9,800,000 | -0.2% | 999,996 | 0.0% | 0.34% | +11.7% | |
| Sell | ARYA SCIENCES ACQUISITN CORP | $9,698,000 | -1.8% | 999,811 | -0.0% | 0.34% | +9.6% | |
| IWM | Sell | ISHARES TRrussell 2000 etf | $9,483,000 | -56.5% | 42,630 | -57.2% | 0.33% | -51.4% |
| TDOC | TELADOC HEALTH INCput | $9,182,000 | -27.6% | 100,000 | 0.0% | 0.32% | -19.2% | |
| HCA | HCA HEALTHCARE INC | $9,146,000 | +5.8% | 35,600 | 0.0% | 0.32% | +18.4% | |
| HERA | Sell | FTAC HERA ACQUISITION CORP | $9,098,000 | -6.6% | 931,191 | -6.9% | 0.32% | +4.2% |
| PAR TECHNOLOGY CORPnote 2.875% 4/1 | $8,820,000 | -10.3% | 6,000,000 | 0.0% | 0.31% | 0.0% | ||
| RILY | Sell | B. RILEY FINANCIAL INC | $8,297,000 | +49.9% | 93,377 | -0.4% | 0.29% | +67.8% |
| ZGNX | ZOGENIX INC | $7,829,000 | +7.0% | 481,782 | 0.0% | 0.28% | +19.0% | |
| LINC | Sell | LINCOLN EDL SVCS CORP | $7,493,000 | -21.9% | 1,003,024 | -30.1% | 0.26% | -12.6% |
| VMD | Sell | VIEMED HEALTHCARE INC | $7,431,000 | -6.6% | 1,423,538 | -0.7% | 0.26% | +4.0% |
| SRL | Buy | SCULLY ROYALTY LTD | $7,151,000 | -16.3% | 807,089 | +7.3% | 0.25% | -6.3% |
| ACAD | ACADIA PHARMACEUTICALS INCcall | $7,002,000 | +40.5% | 300,000 | 0.0% | 0.25% | +56.7% | |
| CBAY | New | CYMABAY THERAPEUTICS INC | $6,760,000 | – | 2,000,142 | +100.0% | 0.24% | – |
| SBTX | Sell | SILVERBACK THERAPEUTICS INC | $6,703,000 | -45.2% | 1,006,462 | -17.9% | 0.24% | -38.9% |
| SSKN | STRATA SKIN SCIENCES INC | $6,704,000 | -20.4% | 4,575,812 | 0.0% | 0.24% | -10.9% | |
| CDTX | New | CIDARA THERAPEUTICS INC | $6,693,000 | – | 5,270,458 | +100.0% | 0.24% | – |
| SGMS | Buy | SCIENTIFIC GAMES CORP | $6,251,000 | +261.3% | 93,533 | +349.1% | 0.22% | +300.0% |
| MAX | New | MEDIAALPHA INCcl a | $5,719,000 | – | 370,404 | +100.0% | 0.20% | – |
| PRTY | PARTY CITY HOLDCO INCcall | $5,570,000 | -21.5% | 1,000,000 | 0.0% | 0.20% | -12.5% | |
| SPCE | VIRGIN GALACTIC HOLDINGS INCcall | $5,352,000 | -47.1% | 400,000 | 0.0% | 0.19% | -41.1% | |
| NAUT | Sell | NAUTILUS BIOTECHNOLOGY INC | $5,335,000 | -16.8% | 1,029,872 | -1.4% | 0.19% | -6.9% |
| New | HYPERFINE INC | $5,210,000 | – | 718,637 | +100.0% | 0.18% | – | |
| IMTXW | Buy | IMMATICS N.V*w exp 07/01/202 | $4,704,000 | +391.0% | 1,071,466 | +373.1% | 0.16% | +450.0% |
| SNDX | New | SYNDAX PHARMACEUTICALS INCcall | $4,378,000 | – | 200,000 | +100.0% | 0.15% | – |
| SLNO | SOLENO THERAPEUTICS INC | $4,004,000 | -55.6% | 9,765,129 | 0.0% | 0.14% | -50.5% | |
| ARYD | ARYA SCIENCES ACQU CORP IVcl a | $3,959,000 | -1.3% | 399,248 | 0.0% | 0.14% | +10.3% | |
| ZGNX | New | ZOGENIX INCcall | $3,842,000 | – | 236,400 | +100.0% | 0.14% | – |
| BGFV | New | BIG 5 SPORTING GOODS CORPput | $3,802,000 | – | 200,000 | +100.0% | 0.13% | – |
| ZVO | Sell | ZOVIO INC | $3,786,000 | -47.2% | 2,980,767 | -0.7% | 0.13% | -41.2% |
| PTON | New | PELOTON INTERACTIVE INC | $3,660,000 | – | 102,342 | +100.0% | 0.13% | – |
| ANGN | Buy | ANGION BIOMEDICA CORP | $3,674,000 | +217.3% | 1,267,029 | +969.0% | 0.13% | +258.3% |
| HARP | Buy | HARPOON THERAPEUTICS INC | $3,590,000 | +8.6% | 475,467 | +13.6% | 0.13% | +21.2% |
| PWP | Sell | PERELLA WEINBERG PARTNERS | $3,577,000 | -43.8% | 278,140 | -42.1% | 0.13% | -37.3% |
| BRPM | New | B RILEY PRINCIPAL 150 MERGER | $3,538,000 | – | 349,649 | +100.0% | 0.12% | – |
| KURA | New | KURA ONCOLOGY INCcall | $3,500,000 | – | 250,000 | +100.0% | 0.12% | – |
| NPCE | Buy | NEUROPACE INC | $3,084,000 | +37.4% | 305,906 | +116.0% | 0.11% | +53.5% |
| PAYO | Sell | PAYONEER GLOBAL INC | $2,930,000 | -47.7% | 398,684 | -39.1% | 0.10% | -41.8% |
| WVE | Sell | WAVE LIFE SCIENCES LTD | $2,848,000 | -41.5% | 907,094 | -8.8% | 0.10% | -35.1% |
| IMAC | Sell | IMAC HLDGS INC | $2,727,000 | -23.7% | 2,392,094 | -0.9% | 0.10% | -15.0% |
| CBIO | Buy | CATALYST BIOSCIENCES INC | $2,524,000 | -74.7% | 2,761,660 | +13.5% | 0.09% | -71.7% |
| IMV | Sell | IMV INC | $2,507,000 | -33.4% | 2,055,212 | -9.4% | 0.09% | -26.1% |
| MILE | Sell | METROMILE INC | $2,452,000 | -63.7% | 1,119,612 | -41.1% | 0.09% | -59.6% |
| IDWM | Sell | IDW MEDIA HLDGS INCcl b | $2,458,000 | -30.3% | 1,229,243 | -1.0% | 0.09% | -22.5% |
| KROS | New | KEROS THERAPEUTICS INCcall | $2,323,000 | – | 39,700 | +100.0% | 0.08% | – |
| New | LUCID DIAGNOSTICS INC | $2,336,000 | – | 435,055 | +100.0% | 0.08% | – | |
| AKBA | New | AKEBIA THERAPEUTICS INCcall | $2,260,000 | – | 1,000,000 | +100.0% | 0.08% | – |
| MACK | MERRIMACK PHARMACEUTICALS IN | $2,229,000 | -19.0% | 569,971 | 0.0% | 0.08% | -10.3% | |
| XGN | Sell | EXAGEN INC | $2,174,000 | -24.5% | 186,936 | -11.7% | 0.08% | -16.5% |
| ACER | Sell | ACER THERAPEUTICS INC | $2,055,000 | -12.2% | 901,290 | -1.4% | 0.07% | -2.7% |
| LVTX | Sell | LAVA THERAPEUTICS NV | $1,984,000 | -9.2% | 360,808 | -2.3% | 0.07% | +1.4% |
| FARADAY FUTRE INTLGT ELCTR I | $1,862,000 | -43.6% | 350,000 | 0.0% | 0.07% | -36.5% | ||
| HTGM | Sell | HTG MOLECULAR DIAGNOSTICS IN | $1,816,000 | -8.4% | 335,015 | -3.5% | 0.06% | +3.2% |
| FVAM | Sell | 5 01 ACQUISITION CORP | $1,792,000 | -1.5% | 181,927 | -1.8% | 0.06% | +10.5% |
| New | AURA BIOSCIENCES INC | $1,683,000 | – | 99,146 | +100.0% | 0.06% | – | |
| Sell | IN8BIO INC | $1,638,000 | -36.2% | 373,169 | -0.5% | 0.06% | -28.4% | |
| Sell | UNICYCIVE THERAPEUTICS INC | $1,415,000 | -28.6% | 686,756 | -1.9% | 0.05% | -19.4% | |
| PWPPW | PERELLA WEINBERG PARTNERS*w exp 12/31/202 | $1,412,000 | +11.7% | 400,000 | 0.0% | 0.05% | +25.0% | |
| New | COGNITION THERAPEUTICS INC | $1,325,000 | – | 209,588 | +100.0% | 0.05% | – | |
| ATXI | Buy | AVENUE THERAPEUTICS INC | $1,319,000 | +2831.1% | 1,453,166 | +4710.1% | 0.05% | +4500.0% |
| CABA | New | CABALETTA BIO INC | $1,294,000 | – | 341,538 | +100.0% | 0.05% | – |
| HOOK | Sell | HOOKIPA PHARMA INC | $1,103,000 | -62.2% | 473,566 | -4.4% | 0.04% | -57.6% |
| TANGO THERAPEUTICS INC | $1,094,000 | -15.4% | 100,000 | 0.0% | 0.04% | -7.3% | ||
| TACT | TRANSACT TECHNOLOGIES INC | $835,000 | -21.6% | 76,583 | 0.0% | 0.03% | -14.7% | |
| ELOX | Sell | ELOXX PHARMACEUTICALS INC | $632,000 | -67.9% | 894,659 | -26.0% | 0.02% | -64.5% |
| GLMD | Sell | GALMED PHARMACEUTICALS LTD | $542,000 | -48.1% | 297,947 | -20.5% | 0.02% | -42.4% |
| FTCVW | FINTECH ACQUISITION CORP V*w exp 12/31/202 | $490,000 | -29.7% | 333,331 | 0.0% | 0.02% | -22.7% | |
| New | BAKKT HOLDINGS INC | $447,000 | – | 52,499 | +100.0% | 0.02% | – | |
| GUARDFORCE AI CO LTD*w exp 09/01/202 | $333,000 | -30.6% | 600,000 | 0.0% | 0.01% | -20.0% | ||
| KTRA | KINTARA THERAPEUTICS INC | $338,000 | -41.9% | 663,279 | 0.0% | 0.01% | -33.3% | |
| OCGN | New | OCUGEN INC | $289,000 | – | 63,606 | +100.0% | 0.01% | – |
| HERAW | FTAC HERA ACQUISITION CORP*w exp 02/28/202 | $237,000 | -7.8% | 249,997 | 0.0% | 0.01% | 0.0% | |
| IIIIW | INSU ACQUISITION CORP III*w exp 12/31/202 | $185,000 | -36.6% | 333,332 | 0.0% | 0.01% | -22.2% | |
| BRPMW | New | B RILEY PRINCIPAL 150 MERGER*w exp 03/01/202 | $181,000 | – | 124,997 | +100.0% | 0.01% | – |
| ROCRW | ROTH CH ACQUISITION III CO*w exp 02/26/202 | $109,000 | -14.8% | 99,749 | 0.0% | 0.00% | 0.0% | |
| FALCON MINERALS CORP*w exp 07/21/202 | $122,000 | -3.9% | 878,022 | 0.0% | 0.00% | 0.0% | ||
| MILEW | METROMILE INC*w exp 02/09/202 | $78,000 | -83.6% | 558,296 | 0.0% | 0.00% | -80.0% | |
| BRPMU | Sell | B RILEY PRINCIPAL 150 MERGERunit 99/99/9999 | $0 | -100.0% | 9 | -100.0% | 0.00% | -100.0% |
| IIIIU | New | INSU ACQUISITION CORP IIIunit 12/31/2026 | $0 | – | 4 | +100.0% | 0.00% | – |
| HERAU | New | FTAC HERA ACQUISITION CORPunit 02/28/2026 | $0 | – | 9 | +100.0% | 0.00% | – |
| RGS | Exit | REGIS CORP MINN | $0 | – | -15,268 | -100.0% | -0.00% | – |
| CYRN | Exit | CYREN LTD | $0 | – | -152,393 | -100.0% | -0.00% | – |
| Exit | TELIGENT INC NEW | $0 | – | -525,952 | -100.0% | -0.01% | – | |
| Exit | CARIBOU BIOSCIENCES INC | $0 | – | -56,418 | -100.0% | -0.04% | – | |
| RGS | Exit | REGIS CORP MINNput | $0 | – | -500,000 | -100.0% | -0.06% | – |
| TFFP | Exit | TFF PHARMACEUTICALS INC | $0 | – | -271,067 | -100.0% | -0.07% | – |
| Exit | GUARDFORCE AI CO LTD | $0 | – | -533,128 | -100.0% | -0.07% | – | |
| ACET | Exit | ADICET BIO INC | $0 | – | -310,540 | -100.0% | -0.08% | – |
| KIRK | Exit | KIRKLANDS INCput | $0 | – | -132,500 | -100.0% | -0.08% | – |
| Exit | TMC THE METALS COMPANY INC | $0 | – | -700,000 | -100.0% | -0.10% | – | |
| HCAQ | Exit | HEALTHCOR CATALIO ACQU CORP | $0 | – | -354,296 | -100.0% | -0.11% | – |
| ATHN | Exit | ATHENA TECHNOLOGY ACQUISI CO | $0 | – | -499,586 | -100.0% | -0.16% | – |
| DVD | Exit | DOVER MOTORSPORTS INC | $0 | – | -2,586,043 | -100.0% | -0.20% | – |
| EXAS | Exit | EXACT SCIENCES CORPput | $0 | – | -150,000 | -100.0% | -0.45% | – |
| VG | Exit | VONAGE HLDGS CORPcall | $0 | – | -1,250,000 | -100.0% | -0.64% | – |
| RHP | Exit | RYMAN HOSPITALITY PPTYS INCput | $0 | – | -300,000 | -100.0% | -0.79% | – |
| MRK | Exit | MERCK & CO INCcall | $0 | – | -600,000 | -100.0% | -1.42% | – |
| VG | Exit | VONAGE HLDGS CORP | $0 | – | -2,962,298 | -100.0% | -1.50% | – |
| CAR | Exit | AVIS BUDGET GROUPput | $0 | – | -550,000 | -100.0% | -2.02% | – |
| QADA | Exit | QAD INCcl a | $0 | – | -926,756 | -100.0% | -2.55% | – |
| TLT | Exit | ISHARES TRput | $0 | – | -600,000 | -100.0% | -2.73% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
About Nantahala Capital Management
Nantahala Capital Management is a hedge fund that was founded in 2004 by Wil Harkey. The firm is headquartered in Connecticut and has additional offices in New York and North Carolina. Nantahala Capital Management primarily invests in the technology, healthcare, and consumer sectors. The firm has a long-term investment approach and seeks to identify undervalued companies with strong growth potential.
Wil Harkey serves as the CEO and Chief Investment Officer of Nantahala Capital Management. He has over 20 years of experience in the finance industry and previously worked at Goldman Sachs and Maverick Capital. In addition to Harkey, the firm's leadership team includes COO and General Counsel, David Kozak, and CFO, Michael Kozak.
Nantahala Capital Management has a strong track record of generating positive returns for its investors. The firm's flagship fund, the Nantahala Fund, has delivered an annualized return of over 20% since its inception in 2006. The firm's success can be attributed to its disciplined investment approach and focus on long-term value creation.
Overall, Nantahala Capital Management is a well-respected hedge fund with a talented leadership team and a strong track record of performance. However, as with any investment, it is important for investors to conduct their own due diligence and carefully consider the risks before investing in the firm's funds.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES TR | 42 | Q3 2023 | 27.2% |
| CODEXIS INC | 42 | Q3 2023 | 3.9% |
| PATHWARD FINANCIAL INC | 35 | Q3 2023 | 6.3% |
| SCIENTIFIC GAMES CORP | 34 | Q3 2022 | 5.3% |
| DOVER MOTORSPORTS INC | 34 | Q3 2021 | 0.5% |
| GOLDEN ENTMT INC | 33 | Q3 2023 | 2.1% |
| QAD INC | 32 | Q3 2021 | 2.6% |
| SCIENTIFIC GAMES CORP | 31 | Q4 2021 | 7.7% |
| DOLBY LABORATORIES INC | 31 | Q4 2020 | 5.6% |
| LINCOLN EDL SVCS CORP | 31 | Q4 2021 | 0.7% |
View Nantahala Capital Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AYTU BIOPHARMA, INC | June 16, 2023 | 1,086,812 | 19.7% |
| Acer Therapeutics Inc. | February 14, 2023 | 1,226,191 | 7.5% |
| Aeglea BioTherapeutics, Inc. | February 14, 2023 | 4,611,302 | 7.5% |
| AKUMIN INC. | February 14, 2023 | 2,206,960 | 2.5% |
| ALTA EQUIPMENT GROUP INC. | February 14, 2023 | 1,188,985 | 3.7% |
| Apollo Endosurgery, Inc. | February 14, 2023 | 4,056,627 | 9.9% |
| Autolus Therapeutics plc | February 14, 2023 | 7,782,018 | 4.7% |
| Bioventus Inc. | February 14, 2023 | 3,168,574 | 5.1% |
| CATALYST BIOSCIENCES, INC. | February 14, 2023 | 438,055 | 1.4% |
| Drive Shack Inc. | February 14, 2023 | 6,500,000 | 7.0% |
View Nantahala Capital Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-21 |
| 4 | 2024-03-15 |
| SC 13G | 2024-03-11 |
| 13F-HR/A | 2024-02-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Nantahala Capital Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.